NDC 70518-0174-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0174
- Requested NDC
- 70518-0174-01
- Package NDCs from labels
- 70518-0174-0, 70518-0174-1, 70518-0174-2, 70518-0174-3, 70518-0174-4, 70518-0174-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | REMEDYREPACK INC. | 2026-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0174-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 | |
| 70518-0174-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 | |
| 70518-0174-2 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0174-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0174-4 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0174 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 21 | Current NDC, Legacy NDC, 5 package rows | 20250424_408e797a-2cf3-4ee6-9f9b-179a8cf3d799.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INZIRQO | HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | 41aaea48-6c1b-42c8-a96f-5923d49dc934 | 2025-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 9cd5d16e-3db7-4b25-847d-6de91543463b | 2025-12-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2025-12-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDE | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 261dd83f-8048-488f-8b71-c4abd9692720 | 2025-12-10 | Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Sun Pharmaceutical Industries, Inc. | d7fa3c79-9f26-415b-8039-eb2acabcf66b | 2025-12-09 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma Inc | 578f74ea-53d1-4c44-b872-66033292abe0 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma Inc | ff7b2d81-9006-465d-9095-1bd8696a12a6 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 197885 E7199S1YWR 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma, Inc. | 5bacc909-6b02-4815-85ef-55fd25b1b1f7 | 2025-12-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | QPharma Inc | b17cd16b-8d0a-4cfa-bd48-2529983fcd12 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Cadista Pharmaceuticals Inc. | e0b74a86-3d36-1af0-e538-41b45b8d2cc3 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | QPharma, Inc. | cfd31165-5902-4c94-8fff-2940faa983c1 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | QPharma, Inc. | c3bcfcae-a9ab-4a57-876d-8749ab6c2cff | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril/HCTZ | LISINOPRIL/HCTZ | Direct_Rx | 4510c108-2683-f505-e063-6394a90ab0a4 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | QPharma Inc | f795db5e-d5ef-4a20-e053-6394a90a7fda | 2025-12-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | QPharma, Inc. | bd436b8b-98a6-584c-e053-2995a90ac15d | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f5f462c6-0604-49d3-af8f-fecbde23be99 | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Hikma Pharmaceuticals USA Inc. | 17561aae-f0bc-4ffc-a007-985b17e9baf0 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.